Clinical trial
A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic…
NCT00392587 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00392587 |
|---|---|
| Title | A Study To Investigate The Effects Of GW856553 On Patients With COPD (Chronic Obstructive Pulmonary Disease) |
| Official title | A Randomised, Double-blind, Placebo-controlled Parallel Study to Assess the Safety, Tolerability,Pharmacodynamics and Steady State Pharmacokinetics of Repeated Doses of GW856553 in Patients With COPD |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive, Chronic Obstructive Pulmonary Disease (COPD) |
| Intervention type | Drug |
| Interventions | GW856553 |
| Enrollment | 30 |
| Start date | Aug 1, 2006 |
| First posted | Oct 26, 2006 |
| Last update posted | Jun 4, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: